ID: ALA71333

Max Phase: Preclinical

Molecular Formula: C24H19F8NO3

Molecular Weight: 521.40

Molecule Type: Small molecule

Representations

Canonical SMILES:  OC(CN(Cc1cccc(OC(F)(F)C(F)F)c1)c1cccc(Oc2ccc(F)cc2)c1)C(F)(F)F

Standard InChI:  InChI=1S/C24H19F8NO3/c25-16-7-9-18(10-8-16)35-19-5-2-4-17(12-19)33(14-21(34)23(28,29)30)13-15-3-1-6-20(11-15)36-24(31,32)22(26)27/h1-12,21-22,34H,13-14H2

Standard InChI Key:  ZHUQKYBEVUVRAV-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 521.40

Molecular Weight (Monoisotopic): 521.1237

AlogP: 6.78

#Rotatable Bonds: 10

Polar Surface Area: 41.93

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 11.04

CX Basic pKa:

CX LogP: 6.93

CX LogD: 6.93

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.30

Np Likeness Score: -1.02

References

1. Reinhard EJ, Wang JL, Durley RC, Fobian YM, Grapperhaus ML, Hickory BS, Massa MA, Norton MB, Promo MA, Tollefson MB, Vernier WF, Connolly DT, Witherbee BJ, Melton MA, Regina KJ, Smith ME, Sikorski JA..  (2003)  Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.,  46  (11): [PMID:12747787] [10.1021/jm020528+]

2. Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO..  (2010)  Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.,  45  (4): [PMID:20116902] [10.1016/j.ejmech.2009.12.070]

3. Kelkar MA, Pednekar DV, Pimple SR, Akamanchi KG.  (2004)  3D QSAR STUDIES OF INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN (CETP) BY CoMFA, CoMSIA AND GFA METHODOLOGIES,  13  (8): [10.1007/s00044-004-0104-9]

Source

Source(1):

• Scientific Literature